A physician asks the pharmacist about obtaining a Special Access Programme (SAP) medication. Which of the following statements is true regarding accessing medications through SAP?

The correct statement is D. The Special Access Programme (SAP) allows access to medications that are not yet approved for use in Canada, but may benefit patients with serious or life-threatening conditions. While SAP authorization does not guarantee the safety or effectiveness of the drug, it does allow for use under certain circumstances. Additionally, the program does not provide medications for free, and the duration of authorization may vary. The manufacturer also has the final authority on whether to provide the requested drug, which is why it is important for the physician to discuss this option with the pharmacist.